Korea Investment Partners logo

Korea Investment Partners

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Korea Investment Partners (KIP) is a highly prominent and established venture capital and private equity firm, headquartered in Seoul, South Korea. Founded in 1986, KIP boasts a long and distinguished history in the investment landscape, making it one of the oldest and most experienced VC firms in Asia. The firm has a significant global footprint, with additional offices in key innovation hubs such as Shanghai, Beijing, Sunnyvale, and Singapore, enabling it to source and support ventures across multiple continents. KIP manages an impressive portfolio, with a total Assets Under Management (AUM) exceeding USD 8.0 billion across over 200 funds, demonstrating its substantial capital base and extensive investment capacity.

KIP's investment strategy is notably broad, encompassing various stages from early-stage startups to mature growth companies. While sector-agnostic, the firm has developed deep expertise and a strong track record in critical sectors including information technology (IT), biotechnology/healthcare, media, consumer goods, and advanced manufacturing. Their global presence allows them to identify and support promising companies not only within South Korea but also across China, Southeast Asia, and the United States. KIP is known for its hands-on approach, providing strategic guidance, operational support, and leveraging its extensive network to help portfolio companies scale and achieve market leadership.

With investments in over 1,000 companies globally, KIP has played a pivotal role in the growth of numerous successful enterprises, including several unicorns and companies that have achieved successful IPOs. Their deep experience and substantial capital base enable them to lead significant funding rounds, often acting as a cornerstone investor in high-potential ventures. The firm's commitment extends beyond capital, focusing on long-term partnerships and fostering innovation across diverse industries. KIP's robust track record underscores its position as a leading force in the global venture capital and private equity ecosystem.

Investor Profile

Korea Investment Partners has backed more than 133 startups, with 41 new investments in the last 12 months alone. The firm has led 24 rounds, about 18% of its total and boasts 41 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series B, Seed rounds (top funding stages).
  • Majority of deals are located in South Korea, United States, China.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 6 rounds in the past year.
  • Typical check size: $1M – $50M.

Stage Focus

  • Series A (35%)
  • Series B (29%)
  • Seed (14%)
  • Series C (11%)
  • Series Unknown (7%)
  • Series D (2%)
  • Series E (2%)
  • Secondary Market (1%)
  • Post Ipo Equity (1%)
  • Convertible Note (1%)

Country Focus

  • South Korea (43%)
  • United States (26%)
  • China (7%)
  • Finland (4%)
  • Israel (4%)
  • Singapore (3%)
  • United Kingdom (3%)
  • France (2%)
  • Belgium (2%)
  • India (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Software
  • Information Technology
  • Pharmaceutical
  • Artificial Intelligence (Ai)
  • E-commerce
  • Gaming
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Korea Investment Partners frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 7
CRIT Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 7
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 6
DSC Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 9
Mirae Asset Venture Investment
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 10
FuturePlay
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 6
Aju IB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Yeoksamdong
Co-Investments: 4
Shinhan Venture Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 5
Company K Partners
Asia, Seoul-t'ukpyolsi, South Korea, Ilsangu
Co-Investments: 5
KB Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 16

Which angels does Korea Investment Partners often collaborate with?

Balaji Srinivasan
Asia, Central Region, Singapore, Singapore
Shared Deals: 1
JB
North America, California, United States, Menlo Park
Shared Deals: 2
MD
North America, Massachusetts, United States, Northampton
Shared Deals: 1
BL
North America, California, United States, San Francisco
Shared Deals: 1
PF
North America, Massachusetts, United States, Boston
Shared Deals: 1
RD
North America, Massachusetts, United States, Boston
Shared Deals: 1
YM
North America, California, United States, Los Altos Hills
Shared Deals: 2
RS
North America, California, United States, Los Angeles
Shared Deals: 1
GK
North America, Nevada, United States, Crystal Bay
Shared Deals: 1
PH
Europe, England, United Kingdom, London
Shared Deals: 1

What are some of recent deals done by Korea Investment Partners?

Mustbio

Seoul, Seoul-t'ukpyolsi, South Korea

MustBio utilizes multi-antibody technology to develop immuno-oncology therapeutics.

BiotechnologyHealth CareMedicalOncology
Series CMar 13, 2026
Amount Raised: $23,289,084
Refilled

Seoul, Seoul-t'ukpyolsi, South Korea

Refilled offers tailored hair loss home care services based on scientific hair loss study findings.

Consumer GoodsCosmeticsHealth CareHealth DiagnosticsPersonal HealthWellness
Series UnknownMar 3, 2026
Amount Raised: $7,502,384
BreezeBio

South San Francisco, California, United States

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

BiotechnologyGeneticsPharmaceuticalTherapeutics
Series BFeb 25, 2026
Amount Raised: $60,000,000
Eezee

Singapore, Central Region, Singapore

At Eezee, we aim to streamline the lengthy and tedious procurement process with the use of technology.

AerospaceCivil EngineeringConstructionE-Commerce PlatformsIndustrial EngineeringProcurementSupply Chain Management
Series BFeb 24, 2026
Amount Raised: $5,000,000
Orum Therapeutics

Daejeon, Taejon-jikhalsi, South Korea

Private biotech company creating cell penetrating therapeutic antibodies

BiotechnologyHealth CareTherapeutics
Post Ipo EquityDec 18, 2025
Amount Raised: $98,281,097
Humanscape

Seoul, Seoul-t'ukpyolsi, South Korea

Humanscape is a health-tech startup which operates blockchain-based, rare disease patient health data platform.

Big DataBlockchainHealth CareInformation Technology
Series CDec 14, 2025
Amount Raised: $3,390,037
Pharos iBio Co.

Anyang, Kyonggi-do, South Korea

Pharos iBio Co. specializing in drug development that develops treatments for intractable diseases.

BiotechnologyHealth CareInformation Technology
Post Ipo DebtDec 4, 2025
Amount Raised: $12,917,990
Sionic AI

Seoul, Seoul-t'ukpyolsi, South Korea

Sionic AI is a technology company that allows users to design, manage, and utilize artificial intelligence in corporate environments.

Artificial Intelligence (AI)Generative AIInformation Technology
Series ADec 1, 2025
Amount Raised: $17,005,485

Best R a company building a tungsten circular economy infrastructure

Series ANov 27, 2025
Future Connect

Seoul, Seoul-t'ukpyolsi, South Korea

Future Connect grows food indoors through an urban production network, fixing supply-chain issues and enabling harvest-to-table freshness.

Food DeliveryGroceryOnline PortalsOrganic Food
Series ANov 26, 2025
Amount Raised: $5,832,254

Find More Investors Like Korea Investment Partners

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides